FASLG and autoimmune polyendocrinopathy: Patients presenting clinical signs of APS which are persistently negative for the consensus-aPL are often labeled as seronegative-APS patients (SN-APS) [29] a concept that, while it is not fully accepted, [39] could serve to label patients that, in our two groups, develop pathology consistent with APS during the follow-up.